A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary

NCT06279104 · clinicaltrials.gov ↗

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Clear Cell Carcinoma

Interventions

DRUG: physician's choice of chemotherapy
DRUG: immune checkpoint inhibitor based therapy

Sponsor

Tongji Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]